Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion type Assertion NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_head.
- NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion description "[Considering the significant responses in a Phase I clinical trial of a non-replicating Ad.5-mda-7 in advanced cancers, Ad.5/3-CTV may exert improved therapeutic benefit in a clinical setting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_provenance.
- NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion evidence source_evidence_literature NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_provenance.
- NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion SIO_000772 23868767 NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_provenance.
- NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion wasDerivedFrom befree-20140225 NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_provenance.
- NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_assertion wasGeneratedBy ECO_0000203 NP204165.RAobK1ThrXNJ7t5h-usuRg6CQToGdj5WduP_5c73nnMTg130_provenance.